7421 - 7430 of 7785 Results
Title
Year
- Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats2011RESTRICTEDTitle: Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 60Issue #: 6Start Page: 861End Page: 868Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2010.12.032Best OA location URL: https://europepmc.org/articles/pmc3133531?pdf=renderCitation Count: 71
- Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures2011RESTRICTEDTitle: Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structuresJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 118Issue #: 5Start Page: 795End Page: 808Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-011-0653-2Best OA location URL: https://europepmc.org/articles/pmc3376651?pdf=renderCitation Count: 250
- Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s disease2011RESTRICTEDTitle: Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 122Issue #: 1Start Page: 49End Page: 60Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-011-0831-1Best OA location URL: https://europepmc.org/articles/pmc3362487?pdf=renderCitation Count: 80
- Sequential requirements for the GTPase domain of the mitofusin Fzo1 and the ubiquitin ligase SCFMdm30 in mitochondrial outer membrane fusion2011RESTRICTEDTitle: Sequential requirements for the GTPase domain of the mitofusin Fzo1 and the ubiquitin ligase SCFMdm30 in mitochondrial outer membrane fusionJournal Name: Journal of Cell SciencePublisher: The Company of BiologistsVol: 124Issue #: 9Start Page: 1403End Page: 1410Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1242/jcs.079293Best OA location URL: https://europepmc.org/articles/pmc3078809Citation Count: 69
-
RESTRICTEDTitle: Rationale for Therapeutic Silencing of Alpha-Synuclein in Parkinson’s DiseaseJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 4Issue #: 1Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.14802/jmd.11001Best OA location URL: https://doi.org/10.14802/jmd.11001Citation Count: 15
- Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications2011RESTRICTEDTitle: Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applicationsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 8Start Page: 1386End Page: 1397Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23737Best OA location URL: https://europepmc.org/articles/pmc3150637?pdf=renderCitation Count: 36
-
RESTRICTEDTitle: Priorities in Parkinson's disease researchJournal Name: Nature Reviews Drug DiscoveryPublisher: Springer Science and Business Media LLCVol: 10Issue #: 5Start Page: 377End Page: 393Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nrd3430Citation Count: 369
-
RESTRICTEDTitle: Biomarkers for Parkinson’s DiseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 3Issue #: 79Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.3002488Citation Count: 34
- Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinations2011RESTRICTEDTitle: Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinationsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 9Start Page: 1781End Page: 1783Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23655Best OA location URL: https://europepmc.org/articles/pmc3142314?pdf=renderCitation Count: 17
-
RESTRICTEDTitle: A Genome-Wide Linkage Screen in the Amish with Parkinson Disease Points to Chromosome 6Journal Name: Annals of Human GeneticsPublisher: WileyVol: 75Issue #: 3Start Page: 351End Page: 358Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1469-1809.2011.00643.xBest OA location URL: https://europepmc.org/articles/pmc3077806?pdf=renderCitation Count: 10